Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Return on Equity: 2018-2020

Historic Return on Equity for Cogent Biosciences (COGT) over the last 3 years, with Dec 2020 value amounting to -0.77%.

  • Cogent Biosciences' Return on Equity rose 28.00% to -0.77% in Q4 2020 from the same period last year, while for Dec 2020 it was -0.77%, marking a year-over-year increase of 28.00%. This contributed to the annual value of -0.62% for FY2020, which is 8.00% up from last year.
  • According to the latest figures from Q4 2020, Cogent Biosciences' Return on Equity is -0.77%, which was down 101.66% from 46.62% recorded in Q3 2020.
  • In the past 5 years, Cogent Biosciences' Return on Equity ranged from a high of 46.62% in Q3 2020 and a low of -3.89% during Q2 2018.
  • For the 3-year period, Cogent Biosciences' Return on Equity averaged around 2.96%, with its median value being -0.84% (2020).
  • In the last 5 years, Cogent Biosciences' Return on Equity plummeted by 121bps in 2019 and then surged by 4,787bps in 2020.
  • Cogent Biosciences' Return on Equity (Quarterly) stood at -0.55% in 2018, then plummeted by 51bps to -1.06% in 2019, then grew by 28bps to -0.77% in 2020.
  • Its Return on Equity was -0.77% in Q4 2020, compared to 46.62% in Q3 2020 and -1.03% in Q2 2020.